Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site Selection

Retroviruses differ in their preferences for sites for viral DNA integration in the chromosomes of infected cells. Human immunodeficiency virus (HIV) integrates preferentially within active transcription units, whereas murine leukemia virus (MLV) integrates preferentially near transcription start sites and CpG islands. We investigated the viral determinants of integration-site selection using HIV chimeras with MLV genes substituted for their HIV counterparts. We found that transferring the MLV integrase (IN) coding region into HIV (to make HIVmIN) caused the hybrid to integrate with a specificity close to that of MLV. Addition of MLV gag (to make HIVmGagmIN) further increased the similarity of target-site selection to that of MLV. A chimeric virus with MLV Gag only (HIVmGag) displayed targeting preferences different from that of both HIV and MLV, further implicating Gag proteins in targeting as well as IN. We also report a genome-wide analysis indicating that MLV, but not HIV, favors integration near DNase I–hypersensitive sites (i.e., +/− 1 kb), and that HIVmIN and HIVmGagmIN also favored integration near these features. These findings reveal that IN is the principal viral determinant of integration specificity; they also reveal a new role for Gag-derived proteins, and strengthen models for integration targeting based on tethering of viral IN proteins to host proteins.

[1]  F. Bushman,et al.  Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences , 2004, PLoS biology.

[2]  F. Bushman.  Targeting Survival Integration Site Selection by Retroviruses and LTR-Retrotransposons , 2003, Cell.

[3]  Howard Cedar,et al.  Selective degradation of integrated murine leukemia proviral DNA by deoxyribonucleases , 1977, Cell.

[4]  I. Verma,et al.  Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene , 1985, Molecular and cellular biology.

[5]  D. Voytas,et al.  Tagging chromatin with retrotransposons: target specificity of the Saccharomyces Ty5 retrotransposon changes with the chromosomal localization of Sir3p and Sir4p. , 1999, Genes & development.

[6]  Pamela A Silver,et al.  Human cell proteins and human immunodeficiency virus DNA integration. , 2004, Frontiers in bioscience : a journal and virtual library.

[7]  Alice Young,et al.  Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H L Robinson,et al.  Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin , 1986, Journal of virology.

[9]  R. Jaenisch,et al.  Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites , 1987, Journal of virology.

[10]  M. Daly,et al.  Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). , 2005, Genome research.

[11]  M. Emerman,et al.  Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells , 2004, Journal of Virology.

[12]  S. Devine,et al.  Yeast Retrotransposons: Finding a Nice Quiet Neighborhood , 1998, Cell.

[13]  M. Emerman,et al.  Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. , 1991, Virology.

[14]  Paul Shinn,et al.  A role for LEDGF/p75 in targeting HIV DNA integration , 2005, Nature Medicine.

[15]  M. Malim,et al.  Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes , 1991, The Journal of experimental medicine.

[16]  A. Bird.  CpG-rich islands and the function of DNA methylation , 1986, Nature.

[17]  Mary K. Lewinski,et al.  Genome-Wide Analysis of Chromosomal Features Repressing Human Immunodeficiency Virus Transcription , 2005, Journal of Virology.

[18]  Paul Shinn,et al.  Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  M. Emerman,et al.  The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection , 1995, Journal of virology.

[20]  Patrick L. Hindmarsh,et al.  Retroviral DNA Integration , 1984, Microbiology and Molecular Biology Reviews.

[21]  Alan M. Lambowitz,et al.  Mobile DNA III , 2002 .

[22]  R. Stoyanova,et al.  Genome-Wide Analyses of Avian Sarcoma Virus Integration Sites , 2004, Journal of Virology.

[23]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[24]  D. S. Gross,et al.  Nuclease hypersensitive sites in chromatin. , 1988, Annual review of biochemistry.

[25]  M. Emerman,et al.  The Cell Cycle Independence of HIV Infections Is Not Determined by Known Karyophilic Viral Elements , 2005, PLoS pathogens.

[26]  Zeger Debyser,et al.  HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells* , 2003, The Journal of Biological Chemistry.

[27]  S. Sandmeyer,et al.  Integration by design , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[29]  M. Emerman,et al.  Human immunodeficiency virus infection of cells arrested in the cell cycle. , 1992, The EMBO journal.

[30]  Stephen E. Fienberg,et al.  Discrete Multivariate Analyses: Theory and Practice , 1977 .

[31]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[32]  M. Llano,et al.  Lens Epithelium-derived Growth Factor/p75 Prevents Proteasomal Degradation of HIV-1 Integrase* , 2004, Journal of Biological Chemistry.

[33]  Paul Shinn,et al.  HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  F. Bushman,et al.  Retroviral DNA integration directed by HIV integration protein in vitro. , 1990, Science.

[35]  S. Burgess,et al.  Weak Palindromic Consensus Sequences Are a Common Feature Found at the Integration Target Sites of Many Retroviruses , 2005, Journal of Virology.

[36]  Robert Craigie,et al.  The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro , 1990, Cell.

[37]  N. Craig,et al.  Mobile DNA elements: controlling transposition with ATP-dependent molecular switches. , 1998, Trends in biochemical sciences.

[38]  J. V. Moran,et al.  Genomic Deletions Created upon LINE-1 Retrotransposition , 2002, Cell.

[39]  Christof von Kalle,et al.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. , 2003, The New England journal of medicine.

[40]  John M. Coffin,et al.  Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Giovanni Parmigiani,et al.  Human L1 Retrotransposition Is Associated with Genetic Instability In Vivo , 2002, Cell.

[42]  M. Emerman,et al.  Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus , 1994, Journal of virology.

[43]  M. Malim,et al.  Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding , 2000, Journal of Virology.

[44]  F. Bushman,et al.  Chromosome Structure and Human Immunodeficiency Virus Type 1 cDNA Integration: Centromeric Alphoid Repeats Are a Disfavored Target , 1998, Journal of Virology.

[45]  Eric R. Ziegel,et al.  Generalized Linear Models , 2002, Technometrics.

[46]  P. Brown,et al.  Integration of murine leukemia virus DNA depends on mitosis. , 1993, The EMBO journal.

[47]  J. Griffith,et al.  Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration , 1996, Journal of virology.

[48]  M. Llano,et al.  LEDGF/p75 Determines Cellular Trafficking of Diverse Lentiviral but Not Murine Oncoretroviral Integrase Proteins and Is a Component of Functional Lentiviral Preintegration Complexes , 2004, Journal of Virology.